The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
In the latest session, Evolent Health Inc (NYSE: EVH) closed at $9.29 down -5.11% from its previous closing price of $9.79. In other words, the price has decreased by -$5.11 from its previous closing price. On the day, 2.09 million shares were traded. EVH stock price reached its highest trading level at $9.845 during the session, while it also had its lowest trading level at $9.27.
Ratios:
For a deeper understanding of Evolent Health Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.85 and its Current Ratio is at 0.85. In the meantime, Its Debt-to-Equity ratio is 0.90 whereas as Long-Term Debt/Eq ratio is at 0.70.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on January 10, 2025, initiated with a Buy rating and assigned the stock a target price of $15.
On December 03, 2024, BTIG Research reiterated its Buy rating and also upped its target price recommendation from $36 to $29.
Stephens Downgraded its Overweight to Equal-Weight on November 08, 2024, whereas the target price for the stock was revised from $38 to $16.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 06 ’25 when Holder Diane bought 2,735 shares for $9.33 per share. The transaction valued at 25,518 led to the insider holds 70,584 shares of the business.
McCarthy Daniel Joseph bought 11,040 shares of EVH for $99,470 on Mar 06 ’25. The PRESIDENT now owns 389,004 shares after completing the transaction at $9.01 per share. On Mar 07 ’25, another insider, Jelinek Richard M, who serves as the Director of the company, bought 30,000 shares for $9.12 each. As a result, the insider paid 273,750 and bolstered with 15,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EVH now has a Market Capitalization of 1083130368 and an Enterprise Value of 1868490624. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.42 while its Price-to-Book (P/B) ratio in mrq is 1.07. Its current Enterprise Value per Revenue stands at 0.731 whereas that against EBITDA is 19.877.
Stock Price History:
The Beta on a monthly basis for EVH is 1.02, which has changed by -0.6865722 over the last 52 weeks, in comparison to a change of 0.07455289 over the same period for the S&P500. Over the past 52 weeks, EVH has reached a high of $33.63, while it has fallen to a 52-week low of $8.35. The 50-Day Moving Average of the stock is -4.26%, while the 200-Day Moving Average is calculated to be -47.03%.
Shares Statistics:
For the past three months, EVH has traded an average of 2.64M shares per day and 2919760 over the past ten days. A total of 115.04M shares are outstanding, with a floating share count of 113.57M. Insiders hold about 2.59% of the company’s shares, while institutions hold 106.35% stake in the company. Shares short for EVH as of 1743379200 were 15888681 with a Short Ratio of 6.01, compared to 1740700800 on 14200523. Therefore, it implies a Short% of Shares Outstanding of 15888681 and a Short% of Float of 15.509999999999998.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
